期刊
JOURNAL OF TISSUE ENGINEERING
卷 11, 期 -, 页码 -出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/2041731420943839
关键词
Mesenchymal stem cell; chondrogenic factor; cartilage injury; cartilage tissue engineering; cartilage regeneration
资金
- National Natural Science Foundation of Chain [51973216, 51873207, 81671804]
- Program of the Development and Reform Commission of Jilin Province [2018C052-4]
- Science and Technology Development Program of Jilin Province [20200404182YY, 20190304121YY]
- Scientific Research Planning Project of the Education Department of Jilin Province [JJKH20201075KJ]
Cartilage injuries are typically caused by trauma, chronic overload, and autoimmune diseases. Owing to the avascular structure and low metabolic activities of chondrocytes, cartilage generally does not self-repair following an injury. Currently, clinical interventions for cartilage injuries include chondrocyte implantation, microfracture, and osteochondral transplantation. However, rather than restoring cartilage integrity, these methods only postpone further cartilage deterioration. Stem cell therapies, especially mesenchymal stem cell (MSCs) therapies, were found to be a feasible strategy in the treatment of cartilage injuries. MSCs can easily be isolated from mesenchymal tissue and be differentiated into chondrocytes with the support of chondrogenic factors or scaffolds to repair damaged cartilage tissue. In this review, we highlighted the full success of cartilage repair using MSCs, or MSCs in combination with chondrogenic factors and scaffolds, and predicted their pros and cons for prospective translation to clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据